These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30602864)

  • 21. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osseointegration Pharmacology.
    Tamimi F; Wu X
    JDR Clin Trans Res; 2017 Jul; 2(3):211-213. PubMed ID: 30938635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative analysis of anatomopathological changes of gastric mucosa due to long term therapy with proton pump inhibitors: experimental studies x clinical studies.
    de Souza IK; da Silva AL; de Araújo A; Santos FC; Mendonça BP
    Arq Bras Cir Dig; 2013; 26(4):328-34. PubMed ID: 24510044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy.
    Dubois RW; Melmed GY; Henning JM; Laine L
    Aliment Pharmacol Ther; 2004 Jan; 19(2):197-208. PubMed ID: 14723611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosing of proton pump inhibitors in a private hospital in Hong Kong.
    Mui AC; Fan TC
    Hong Kong Med J; 2007 Dec; 13(6):430-5. PubMed ID: 18057430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Techniques for retrievability and for registering screw access holes in cement-retained implant-supported prostheses: A scoping review of the literature.
    Malpartida-Carrillo V; Tinedo-Lopez PL; Ortiz-Culca F; Guerrero ME; Amaya-Pajares SP
    J Prosthet Dent; 2020 Mar; 123(3):427-433. PubMed ID: 31307803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.
    Janett S; Camozzi P; Peeters GG; Lava SA; Simonetti GD; Goeggel Simonetti B; Bianchetti MG; Milani GP
    Gastroenterol Res Pract; 2015; 2015():951768. PubMed ID: 26064102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
    Bashford JN; Norwood J; Chapman SR
    BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
    Hunfeld NG; Geus WP; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jan; 25(1):39-46. PubMed ID: 17229219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of proton pump inhibitors.
    Der G
    Gastroenterol Nurs; 2003; 26(5):182-90. PubMed ID: 14603076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
    Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor.
    Harewood GC; Gostout CJ
    Gastrointest Endosc; 2003 Oct; 58(4):493-9. PubMed ID: 14520279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
    Martin RM; Lim AG; Kerry SM; Hilton SR
    Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review: Proton pump inhibitor-associated acute interstitial nephritis.
    Sierra F; Suarez M; Rey M; Vela MF
    Aliment Pharmacol Ther; 2007 Aug; 26(4):545-53. PubMed ID: 17661758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use.
    Klok RM; Postma MJ; van Hout BA; Brouwers JR
    Aliment Pharmacol Ther; 2003 May; 17(10):1237-45. PubMed ID: 12755837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.
    Ishizaki T; Horai Y
    Aliment Pharmacol Ther; 1999 Aug; 13 Suppl 3():27-36. PubMed ID: 10491726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between proton pump inhibitors and risk of pyogenic liver abscess.
    Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
    Eur J Clin Pharmacol; 2017 Aug; 73(8):1019-1025. PubMed ID: 28434021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.